Simulations Plus (NASDAQ:SLP) Stock Rating Lowered by Zacks Research

Simulations Plus (NASDAQ:SLP) was downgraded by equities researchers at Zacks Research from a “strong-buy” rating to a “hold” rating in a research report issued on Monday,Zacks.com reports.

A number of other equities research analysts have also recently commented on the stock. KeyCorp restated a “sector weight” rating on shares of Simulations Plus in a research note on Wednesday, October 29th. Citigroup reissued a “market perform” rating on shares of Simulations Plus in a research note on Tuesday, January 6th. Weiss Ratings restated a “sell (d-)” rating on shares of Simulations Plus in a research report on Wednesday, October 8th. BTIG Research downgraded shares of Simulations Plus from a “buy” rating to a “neutral” rating in a report on Thursday, December 18th. Finally, TD Cowen reiterated a “hold” rating on shares of Simulations Plus in a research note on Thursday, January 8th. Three analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Simulations Plus presently has a consensus rating of “Hold” and a consensus price target of $25.00.

Simulations Plus Stock Performance

NASDAQ SLP opened at $15.40 on Monday. The business’s fifty day moving average is $18.99 and its 200 day moving average is $16.57. Simulations Plus has a fifty-two week low of $12.39 and a fifty-two week high of $37.67. The company has a market capitalization of $310.31 million, a PE ratio of -4.81 and a beta of 1.12.

Simulations Plus (NASDAQ:SLP) last issued its quarterly earnings results on Thursday, January 8th. The technology company reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.05). Simulations Plus had a positive return on equity of 14.02% and a negative net margin of 81.66%.The company had revenue of $18.42 million during the quarter, compared to analysts’ expectations of $18.05 million. During the same quarter in the previous year, the company earned $0.17 EPS. On average, sell-side analysts forecast that Simulations Plus will post 1.09 EPS for the current year.

Institutional Trading of Simulations Plus

Institutional investors and hedge funds have recently bought and sold shares of the stock. Raymond James Financial Inc. purchased a new stake in Simulations Plus in the 2nd quarter worth $25,000. Quarry LP bought a new stake in shares of Simulations Plus in the third quarter worth about $28,000. CWM LLC lifted its position in shares of Simulations Plus by 3,729.1% in the third quarter. CWM LLC now owns 2,106 shares of the technology company’s stock worth $32,000 after buying an additional 2,051 shares in the last quarter. Farther Finance Advisors LLC bought a new position in Simulations Plus during the third quarter valued at approximately $40,000. Finally, AlphaQuest LLC purchased a new position in Simulations Plus during the 2nd quarter valued at approximately $69,000. 78.08% of the stock is currently owned by institutional investors.

About Simulations Plus

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.